Amalgamated Bank Has $2.59 Million Holdings in Universal Health Services, Inc. (NYSE:UHS)

Posted by Defense World Staff on Jul 29th, 2023

Amalgamated Bank cut its stake in shares of Universal Health Services, Inc. (NYSE:UHS – Free Report) by 36.1% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,397 shares of the health services provider’s stock after selling 11,533 shares during the period. Amalgamated Bank’s holdings in Universal Health Services were worth $2,592,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Cibc World Markets Corp acquired a new stake in Universal Health Services in the fourth quarter valued at $1,063,000. Harvest Fund Management Co. Ltd acquired a new stake in Universal Health Services in the fourth quarter valued at $117,000. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its holdings in Universal Health Services by 21.8% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 47,135 shares of the health services provider’s stock valued at $6,722,000 after purchasing an additional 8,429 shares during the period. Banque Pictet & Cie SA increased its holdings in Universal Health Services by 323.5% in the fourth quarter. Banque Pictet & Cie SA now owns 38,515 shares of the health services provider’s stock valued at $5,426,000 after purchasing an additional 29,421 shares during the period. Finally, Fox Run Management L.L.C. acquired a new stake in Universal Health Services in the fourth quarter valued at $201,000. 84.03% of the stock is currently owned by institutional investors and hedge funds.

Universal Health Services Trading Up 0.5 %

NYSE:UHS opened at $138.74 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.26 and a current ratio of 1.29. The firm has a market cap of $9.74 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 1.89 and a beta of 1.29. Universal Health Services, Inc. has a 52 week low of $82.50 and a 52 week high of $158.57. The firm has a 50-day moving average price of $144.76 and a two-hundred day moving average price of $140.20.

Universal Health Services (NYSE:UHS – Get Free Report) last posted its quarterly earnings results on Tuesday, July 25th. The health services provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.43 by $0.10. The company had revenue of $3.55 billion for the quarter, compared to analysts’ expectations of $3.50 billion. Universal Health Services had a net margin of 5.02% and a return on equity of 12.47%. Universal Health Services’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.20 EPS. On average, equities analysts expect that Universal Health Services, Inc. will post 10.23 earnings per share for the current fiscal year.

Universal Health Services Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Friday, September 1st will be issued a dividend of $0.20 per share. The ex-dividend date is Thursday, August 31st. This represents a $0.80 dividend on an annualized basis and a yield of 0.58%. Universal Health Services’s payout ratio is 8.31%.

Insider Buying and Selling at Universal Health Services

In other news, Director Eileen C. Mcdonnell sold 3,107 shares of the business’s stock in a transaction on Wednesday, May 10th. The shares were sold at an average price of $141.53, for a total transaction of $439,733.71. Following the completion of the transaction, the director now directly owns 5,508 shares in the company, valued at approximately $779,547.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Warren J. Nimetz sold 800 shares of the company’s stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $140.97, for a total value of $112,776.00. Following the completion of the transaction, the director now directly owns 2,944 shares in the company, valued at $415,015.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Eileen C. Mcdonnell sold 3,107 shares of the company’s stock in a transaction dated Wednesday, May 10th. The shares were sold at an average price of $141.53, for a total transaction of $439,733.71. Following the sale, the director now owns 5,508 shares of the company’s stock, valued at $779,547.24. The disclosure for this sale can be found here. Insiders have sold 74,697 shares of company stock valued at $10,547,996 in the last 90 days. 15.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

UHS has been the subject of a number of recent analyst reports. VNET Group reiterated an “assumes” rating on shares of Universal Health Services in a report on Friday, June 2nd. JPMorgan Chase & Co. initiated coverage on Universal Health Services in a report on Wednesday, April 19th. They set a “neutral” rating and a $133.00 price target for the company. Citigroup increased their price target on Universal Health Services from $150.00 to $165.00 in a report on Thursday, April 27th. 888 reissued a “maintains” rating on shares of Universal Health Services in a research report on Monday, May 8th. Finally, Cantor Fitzgerald started coverage on shares of Universal Health Services in a research report on Thursday, April 20th. They set an “underweight” rating and a $143.00 price objective on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $149.00.

About Universal Health Services

(Free Report)

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.